Introduction {#s1}
============

Group A *Streptococcus* (*Streptococcus pyogenes*, GAS) is an exclusively human, Gram-positive pathogen that causes a broad variety of diseases from mild pharyngitis and skin infections to necrotizing fasciitis, streptococcal toxic shock syndrome, and non-suppurative sequelae such as acute rheumatic fever or glumerulonephritis (for a review see [@pone.0009785-Cunningham1]). Since the 1980\'s, GAS has re-emerged as an important cause of severe invasive infections and is estimated to cause approximately 500,000 deaths each year globally despite available antibiotic treatment [@pone.0009785-Carapetis1]. In the late 1800\'s, GAS was identified as a causative factor of puerperal sepsis -- a severe invasive infection in post partum women [@pone.0009785-Pasteur1]. Due to advances in hospital hygiene, namely physicians washing their hands between deliveries, these types of GAS infections became less frequent. However, in the last three decades there has been a resurgence in GAS infections of the female urogenital tract and vulvovaginatis in pre-pubescent females, and invasive postpartum disease now accounts for approximately 2.2% of invasive GAS diseases [@pone.0009785-Chuang1]. Women with pre-existing throat infections or disrupted mucosal and skin barriers during pregnancy and delivery are particularly susceptible [@pone.0009785-Chuang1].

GAS strains are classified based on the aminoterminal sequence of the M protein, a polymorphic cell surface adhesin and anti-phagocytic factor [@pone.0009785-Cunningham1]. Among the various GAS serotypes, serotype M28 strains are a common cause of invasive disease and have an unusual propensity to cause vaginitis and postpartum infections [@pone.0009785-Chuang1]--[@pone.0009785-Green2]. Full-genome sequence analysis of an M28 strain provided the first insight into the underlying molecular mechanism for the ability of these strains to cause a disproportionate number of postpartum infections [@pone.0009785-Green1]. Green et al. identified a mobile genetic element, named Region of Difference (RD) 2, that was present in all serotype M28 strains analyzed and a subset of other M serotype strains that have been linked epidemiologically to maternal-neonatal infections [@pone.0009785-Green1]. Interestingly, RD2 shares extensive similarity with regions in group B *Streptococcus* (*Streptococcus agalactiae*, GBS) [@pone.0009785-Green1], [@pone.0009785-Tettelin1], which is a common cause of female urogenital tract infections, and genes in groups C and G *Streptococcus* (Sitkiewicz I., Green NM., and Musser JM, unpublished) that can also cause severe invasive infections [@pone.0009785-Mylvaganam1], [@pone.0009785-Pinho1].

As mentioned previously, GAS is capable of causing a wide range of diseases by successfully colonizing a variety of anatomical sites. Transcriptome analyses of GAS grown in blood, saliva, epithelial cells, and polymorphonuclear leukocytes (PMNs) have revealed that GAS is extremely adaptable and modifies its transcriptome based on environmental signals [@pone.0009785-Graham1]--[@pone.0009785-Goldmann1]. To establish infection in the female urogenital tract, GAS must survive and replicate in a bacteriostatic host environment. The ability of GBS to persist and replicate in human amniotic fluid (AF) [@pone.0009785-Eidelman1] is an important contributing factor to its ability to cause severe pre- and postpartum infections, despite AF having antibiotic properties towards other bacterial species [@pone.0009785-Pommerenke1]. Because M28 GAS strains contain the RD2 element and cause a disproportionate number of postpartum infections, we hypothesized that serotype M28 GAS would be able to survive and persist in human AF, similarly to GBS. To initially characterize the interaction of pathogenic GAS within this specific host niche, we used an ex vivo strategy to analyze the global transcriptional response of GAS grown in human AF compared to GAS grown under standard laboratory conditions.

Materials and Methods {#s2}
=====================

Bacterial strains and routine growth {#s2a}
------------------------------------

GAS strains MGAS6180 (serotype M28, RD2+) [@pone.0009785-Green1], and MGAS 5005 (serotype M1, RD2-) [@pone.0009785-Sumby1] were grown in Todd Hewitt medium with 0.5% yeast extract or on TSA II plates supplemented with 5% sheep blood (BD Diagnostics) at 37°C in 5% CO~2~.

Growth of bacteria in AF {#s2b}
------------------------

Human (AF) was collected from pregnant women seen at The Methodist Hospital, Houston, Texas, or Weill Medical College of Cornell University in New York City. Samples were collected in accordance with an exempt human subjects protocol approved by the Institution Review Board of each institution. The study involved collection of existing diagnostic specimens routinely collected during clinical procedures as amniocenteses and would have been otherwise discarded. Specimens were stripped of all identifiers and processed in a manner that subjects cannot be directly or indirectly identified.

AF samples were tested to determine if they supported bacterial growth. GAS cells were grown overnight in THY, washed twice in sterile PBS, and re-suspended in PBS to 100×. Ten µl of the 100× bacteria suspension were diluted further in PBS and were used to inoculate each 250 µl sample of heat inactivated (95°C, 5 min) AF, resulting in a final average inoculum of ∼10^4^ CFU/ml. Samples were incubated at 37°C with 5% CO~2~ for 24 h. To avoid THY carryover that might bias the growth results, bacteria were diluted 1∶50 or 1∶25 into a fresh aliquot of AF after the first 24 h. Aliquots were removed, serially diluted, and plated on TSA II plates (BD Diagnostics) every hour for the first 12 h and every 12 h thereafter for CFU enumeration. AF samples that supported growth of GAS were pooled and used for the microarray analysis. Samples were collected from three pooled AF cultures (biological replicates) after 3.5, 5, and 9 hours of growth in AF, which corresponds to bacteria in mid log (ML) growth phase, late log (LL, time point corresponding with the transition from log to stationary phase) and stationary (S) phase, respectively. Bacteria grown in THY laboratory medium were collected in ML, LL and S phase from three independent cultures (biological replicates).

RNA isolation {#s2c}
-------------

The bacteria used for RNA isolation were mixed with 2 volumes of RNA Protect reagent (Qiagen) and cells were collected by centrifugation and stored at −80°C until processing. RNA from GAS was isolated as described previously [@pone.0009785-Sitkiewicz1]. All samples were processed at the same time to minimize experimental error. Reverse transcription, cDNA fragmentation, and labeling for all samples were performed as described previously [@pone.0009785-Sitkiewicz1].

Microarray analysis {#s2d}
-------------------

Microarray analysis was performed using a custom-made Affymetrix chip [@pone.0009785-Shelburne2] that contained 1929 redundant probes representing the core GAS chromosome and 289 redundant probes unique for MGAS6180. A total of 1765 MGAS6180 genes were represented on the array. Chip hybridization and data acquisition and processing were performed as described [@pone.0009785-Sitkiewicz2]. Samples used for microarray analysis were collected from cultures in THY and AF at mid logarithmic (ML), late logarithmic (LL) and stationary (S) growth phases. The average expression values for each transcript in AF in each growth phase was divided by the average expression in THY to generate AF/THY ratios and degree of changes. Genes that had a two-fold change of expression or greater in AF and were statistically significant (P\<0.05) were included in the analysis.

The data is deposited in MIAME-compliant GEO database under accession number GSE19985.

Results and Discussion {#s3}
======================

Characterization of GAS growth in AF {#s3a}
------------------------------------

Human AF is a nutritionally poor environment. AF is composed primarily of water and low amounts of sugars and proteins, levels of which decrease as the pregnancy nears term [@pone.0009785-Sozanskii1]. Recent detailed compositional analysis of AF revealed the presence of multiple proteins (serum albumin, transferrin, α-I-Antitripsin, α-fetoprotein, calpain 6, pinin, type XIII collagen, immunoglobulins) [@pone.0009785-Nilsson1], glucose, fructose, lipids, hormones (estrogen and progesterone), and epithelial cells. Sources of AF are predominantly fetal urine (∼900 ml per day influx at term), tracheal fluid, fetal lung fluid, and water and solvents transferred between AF and fetal blood in placenta [@pone.0009785-Modena1].

GAS rarely causes septic abortions [@pone.0009785-Chuang1]; however, after disruption of membranes, release of AF can change the environment of the female genital tract by increasing pH from acidic to neutral/slightly alkaline and affect balance of natural bacterial vaginal flora. GAS grows better in neutral than acidic pH [@pone.0009785-Beck1], therefore pH change can promote growth of colonizing pathogens and postpartum infection. Because GAS is able to cause postpartum infections suggests that it is able to survive in an environment containing AF.

Individual specimens of AF collected from women at various stages of pregnancy can vary in their bacteriostatic properties, primarily due to the activity of lysozyme, immunoglobins, and β−lysin [@pone.0009785-Galask1]--[@pone.0009785-Larsen2]. In general, samples from early stage pregnancies are less bacteriostatic than samples from late stage pregnancies [@pone.0009785-Evans1]. In addition, bacteriostatic properties of AF also depend on the presence of meconium and iron availability [@pone.0009785-Ahn1]. Often the presence of meconium in AF is used to predict the likelihood of the mother developing a postpartum or intrapartum bacterial infection [@pone.0009785-Tran1].

Therefore we wanted to determine if GAS can survive in bacteriostatic AF and if so, what transcriptional changes it undergoes to achieve this.

To determine if AF had antimicrobial properties towards GAS, we tested samples collected from separate individuals at different stages of pregnancy. About half of the tested specimens did not support the growth of GAS ([Fig 1A](#pone-0009785-g001){ref-type="fig"}). Observed inhibition of GAS growth did not correlate with the gestation period (data not shown), and was instead patient specific and influenced by unknown factors. Visual inspection of AF specimens did not allow determination of the presence of meconium. Growth of GAS in AF was not restricted to the serotype M28 strain, as serotype M1 strain MGAS5005 grew at a comparable density to the M28 strain in one of the individual growth-positive specimens (data not shown). In conclusion, unlike many other bacteria, GAS can survive and grow in some AF specimens, which could have important implications for its ability to cause postpartum infections.

![Characterization of growth of GAS in AF.\
**A**. Individual specimens of AF support growth of GAS at various levels after 24 h of incubation; initial inoculum ∼10^4^ CFU/ml. **B**. Growth densities of GAS (CFU/ml) in THY and AF.](pone.0009785.g001){#pone-0009785-g001}

To further characterize the growth of GAS in AF, we pooled all AF specimens that supported growth of GAS and performed growth curves with two different starting inocula and compared it to GAS grown in laboratory medium (THY) ([Fig. 1B](#pone-0009785-g001){ref-type="fig"}). Interestingly, GAS grown in AF reached similar density (around 2×10^7^ CFU/ml) in stationary phase, despite a three-fold difference in starting inocula. Similar cell density was observed after 48h of incubation in AF. This suggests that the limited nutrient availability of AF could not sustain higher density growth.

Microarray analysis: general quantitative trends in response to AF {#s3b}
------------------------------------------------------------------

To characterize the transcriptional response of GAS grown in AF we utilized an ex vivo microarray approach that has been used previously to characterize the interactions of GAS with various environments such as blood and saliva [@pone.0009785-Graham1], [@pone.0009785-Shelburne1]. We detected 859 differentially expressed genes fulfilling the criteria of differentially expressed gene (∼49% of genes present on the array). Over 250 genes were differentially expressed in ML and LL phases and the number of differentially expressed genes increased and reached maximum in S phase ([Figures 2](#pone-0009785-g002){ref-type="fig"} and [3](#pone-0009785-g003){ref-type="fig"}). The majority of these genes in ML and LL phases were up regulated rather than down regulated. This differs from the response of GBS grown in AF [@pone.0009785-Sitkiewicz2], in which the majority of genes are down regulated when compared to laboratory conditions and the bulk of changes are observed during the transition from logarithmic to stationary phase [@pone.0009785-Sitkiewicz2]. The complete list of transcriptional changes in GAS is shown in [Table S1](#pone.0009785.s001){ref-type="supplementary-material"} and comparison of gene expression between GAS and GBS in [Table S2](#pone.0009785.s002){ref-type="supplementary-material"}.

![Number of genes differentially expressed in response to AF in ML, LL and S phases.\
Upward arrows represent the number of transcripts with increased expression in AF in ML, LL and S phases; the downward arrows represent the number of transcripts with increased expression in THY (down regulated in AF) in ML, LL and S phases. Intersections of the Venn diagram indicate number of differentially expressed genes during more than one growth phase.](pone.0009785.g002){#pone-0009785-g002}

![Dynamics of gene expression of GAS genes in ML, LL, and S phase in response to AF.\
Each dot represents a single transcript and its coordinates are the average level of expression in THY (x-axis) and AF (y-axis). The dotted lines denote 2-fold change in transcription. Transcripts below the lower dotted line are more highly expressed in THY, transcripts above the upper dotted line are more highly expressed in AF. Thick black lines denote 10-fold differences in transcript level between the studied conditions.](pone.0009785.g003){#pone-0009785-g003}

Expression of virulence factors {#s3c}
-------------------------------

Because GAS causes severe invasive postpartum diseases, we were interested in determining which virulence factors exhibited a change in expression in response to AF. Surprisingly, with the exception of CAMP factor, streptodornase, and one of the enterotoxins ([Table 1](#pone-0009785-t001){ref-type="table"}), we did not detect up regulation of virulence factor expression. However, we did detect massive down regulation of genes encoding proteins involved in adhesion, such as multiple fibronectin, collagen and laminin binding proteins, M protein, the gene encoding R28 protein (*M28_Spy1336*), and streptolysin S. Down regulation of multiple adhesins and cell surface proteins could be a mechanism to evade the host immune response. The genes encoding two peptidases that interact with the host immune response, C5A peptidase and SpyCEP, were expressed at much lower levels in AF than in THY ([Table 1](#pone-0009785-t001){ref-type="table"}). C5A peptidase has been also shown to facilitate fibronectin-independent invasion of epithelial cells [@pone.0009785-Purushothaman1]. Similar down regulation of adhesins and capsule was observed in GBS when grown in AF [@pone.0009785-Sitkiewicz2].

10.1371/journal.pone.0009785.t001

###### Differential expression of genes encoding known GAS virulence factors upon contact with AF.

![](pone.0009785.t001){#pone-0009785-t001-1}

  6180            SF370     Locus        ML            LL            S                      Descriptions
  ------------- --------- --------- ------------- ------------ ------------- -------------------------------------------
  M28_Spy0105                         **−4.20**    **−12.76**   **−28.84**           Fibronectin-binding protein
  M28_Spy0107                \-       **−2.49**    **−9.14**     **−7.83**           Fibronectin-binding protein
  M28_Spy0109    SPy0128     \-       **−2.33**    **−5.79**     **−5.36**           Fibronectin-binding protein
  M28_Spy0113                         **−2.49**    **−2.64**    **−16.21**            Collagen adhesion protein
  M28_Spy0754    SPy1054     \-       **−2.41**                  **−1.82**          Collagen-like surface protein
  M28_Spy1675               sclA     **−167.84**   **−13.82**    **−2.83**          Collagen-like surface protein
  M28_Spy1696    SPy2007     lmb                   **−2.90**     **−5.03**         Laminin-binding surface protein
  M28_Spy1702    SPy2018     emm     **−21.63**    **−3.84**                                  M protein
  M28_Spy1715                        **−53.54**    **−8.97**     **−3.47**           Fibronectin-binding protein
  M28_Spy1716                        **−75.85**    **−15.05**    **−5.01**           Fibronectin-binding protein
  M28_Spy1336                        **−53.13**    **−90.92**   **−133.85**                  R28 protein
  M28_Spy0139    SPy0167     slo     **−45.03**                  **2.68**                  Streptolysin O
  M28_Spy0540    SPy0738    sagA                                 **−2.06**            Streptolysin S precursor
  M28_Spy0541    SPy0739    sagB                                **−12.20**       Streptolysin S biosynthesis protein
  M28_Spy0542    SPy0740    sagC                                **−18.65**       Streptolysin S biosynthesis protein
  M28_Spy0543    SPy0741    sagD                                **−15.04**       Streptolysin S biosynthesis protein
  M28_Spy0544    SPy0742    sagE                                **−15.65**       Streptolysin S biosynthesis protein
  M28_Spy0545    SPy0743    sagF                                **−15.06**       Streptolysin S biosynthesis protein
  M28_Spy0546    SPy0744    sagG                                **−18.88**    Streptolysin S export ATP-binding protein
  M28_Spy0547    SPy0745    sagH                                **−16.89**          Streptolysin S export protein
  M28_Spy0548    SPy0746    sagI                                **−14.21**          Streptolysin S export protein
  M28_Spy0180    SPy0212    speG                                 **−2.59**                   Enterotoxin
  M28_Spy0969                         **2.53**                                               Enterotoxin
  M28_Spy0953    SPy1273     cfa      **15.18**     **2.52**                                 cAMP factor
  M28_Spy0968    SPy1436    spd3      **2.26**                                      Streptodornase (EC 3.1.21.1)
  M28_Spy0329    SPy0416   Spy CEP   **−16.21**                  **−2.50**            Endopeptidase lactocepin
  M28_Spy1700    SPy2010    scpA     **−47.34**    **−2.64**                    C5A peptidase precursor (EC 3.4.21.-)

Values represent fold change in expression in AF at ML, LL, and S growth phases compared to expression in THY medium.

R28 is an adhesin encoded by the RD2 element present in MGAS6180 and several other GAS strains [@pone.0009785-Green1]. It is a known virulence factor that increases attachment of GAS to cervical cells [@pone.0009785-StalhammarCarlemalm1]. Its down regulation might be connected to down regulation of *M28_Spy1337*, which encodes a putative regulator; however, this has yet to be tested experimentally. In addition to R28, we observed an increase in transcription levels for multiple genes encoded by RD2 ([Table 2](#pone-0009785-t002){ref-type="table"}). The RD2 element has been suggested to be involved in pathogenesis and adaptation to specific environments [@pone.0009785-Green1]. Interestingly, a large number of RD2 genes differed in their expression among biological replicates; therefore the calculated P value in many cases was greater than 0.05.

10.1371/journal.pone.0009785.t002

###### Differential expression of RD2 genes in response to AF.

![](pone.0009785.t002){#pone-0009785-t002-2}

  Gene                ML        P        LL                 S                    Putative function             note
  ------------- -------------- ---- ------------ ---- ------------- ---- ---------------------------------- -----------
  M28_Spy1304     **10.19**           **6.76**          **16.10**    \+         Hypothetical Protein        
  M28_Spy1305      **2.39**     \+    **2.43**    \+    **1.75**     \+    Hypothetical membrane protein    
  M28_Spy1306     **10.06**     \+    **7.60**    \+    **2.47**                Cell surface protein         Virulence
  M28_Spy1307      **5.13**           **3.98**    \+    **1.08**           Hypothetical exported protein     Virulence
  M28_Spy1308      **5.52**           **2.65**          **3.81**     \+    Hypothetical exported protein     Virulence
  M28_Spy1309      **1.54**     \+    **1.71**    \+    **1.70**     \+         Hypothetical protein        
  M28_Spy1310      **3.41**           **3.13**    \+    **1.78**                  Membrane protein          
  M28_Spy1311    Not detected                                                                               
  M28_Spy1312    Not detected                                                                               
  M28_Spy1313      **8.70**           **6.23**          **2.28**           Hypothetical membrane protein    
  M28_Spy1314      **5.17**           **4.37**    \+    **3.00**                hypothetical protein        
  M28_Spy1315      **5.69**           **7.31**    \+    **3.42**                Hypothetical protein        
  M28_Spy1316      **9.67**           **8.45**          **6.03**                Hypothetical protein        
  M28_Spy1317     **35.90**          **12.95**          **3.67**                Hypothetical protein        
  M28_Spy1318      **3.81**           **2.69**          **6.31**     \+         Hypothetical protein        
  M28_Spy1319    Not detected                                                                               
  M28_Spy1320     **11.20**          **36.55**    \+    **10.89**    \+    Hypothetical cytosolic protein   
  M28_Spy1321    Not detected                                                                               
  M28_Spy1322      **6.26**           **4.41**          **2.37**                FtsK SpoIIIE family         
  M28_Spy1323      **9.05**     \+    **6.88**    \+    **1.61**           Hypothetical cytosolic protein   
  M28_Spy1324      **5.80**           **7.41**    \+    **2.68**           Hypothetical cytosolic protein   
  M28_Spy1325      **3.99**     \+    **2.28**          **1.72**                Cell surface protein         Virulence
  M28_Spy1326      **2.18**     \+    **1.08**          **−1.29**    \+            M like protein            Virulence
  M28_Spy1327     **18.65**           **6.43**          **4.84**           Hypothetical cytosolic protein   
  M28_Spy1328    Not detected                                                                               
  M28_Spy1329     **12.91**           **5.16**          **2.98**          Transcriptional Cro CI regulator  
  M28_Spy1330      **1.80**     \+    **1.75**    \+    **2.23**     \+   Transcriptional Cro CI regulator  
  M28_Spy1331      **2.22**     \+    **2.51**    \+    **4.28**     \+    Hypothetical cytosolic protein   
  M28_Spy1332      **2.42**     \+    **2.50**    \+    **8.66**     \+    Hypothetical exported protein     Virulence
  M28_Spy1333      **1.89**     \+    **1.69**    \+    **5.46**     \+    Hypothetical cytosolic protein   
  M28_Spy1334      **1.74**     \+    **2.35**    \+    **6.34**     \+    DNA-damage-inducible protein J   
  M28_Spy1335      **1.20**           **1.36**          **3.20**                    Transposase             
  M28_Spy1336     **−53.13**    \+   **−90.92**   \+   **−133.85**   \+       R28 Cell surface protein       Virulence
  M28_Spy1337     **−5.18**     \+   **−8.50**    \+    **−7.93**    \+      Transcriptional regulator      

Values represent fold change in expression in AF at ML, LL, and S growth phases compared to expression in THY medium. +: P\<0.05.

Stress response of GAS and GBS to AF {#s3d}
------------------------------------

In contrast to GBS, which does not increase transcription of genes encoding proteins involved in the stress response [@pone.0009785-Sitkiewicz2], GAS activates multiple genes involved in this process. We observed increased transcription of the genes encoding proteolytic complex composed of ATPase and catalytic subunits ( *clpP*, *clpE*, *clpX*, and *clpL*) known to be stress effectors in streptococci [@pone.0009785-Nair1], [@pone.0009785-Robertson1], the GroEL and GroES chaperonins, members of the Gls24 family of stress proteins (stress and starvation inducible genes in *Enterococcus faecalis*, [@pone.0009785-Giard1]), and a putative GTP pyrophosphokinase ([Table 3](#pone-0009785-t003){ref-type="table"}). Expression of the gene *M28_Spy1562* that encodes a putative stress protein, was dramatically decreased in AF; however, its function in GAS is unknown. We also observed lowered expression of the *relA* gene which is major regulator of stringent control in GAS [@pone.0009785-Malke1].

10.1371/journal.pone.0009785.t003

###### Differential expression of stress response genes in response to AF.

![](pone.0009785.t003){#pone-0009785-t003-3}

  6180            SF370    Locus      ML           LL            S                       Descriptions
  ------------- --------- ------- ----------- ------------- ------------ ---------------------------------------------
  M28_Spy0317    SPy0395   clpP                               **3.01**             proteolytic subunit clpP
  M28_Spy1179    SPy1509   clpE    **2.01**     **2.64**      **2.04**             ATP-binding subunit clpE
  M28_Spy0659    SPy0873    \-                                **2.05**               GTP pyrophosphokinase
  M28_Spy0671              clpX                              **−6.23**             ATP-binding subunit clpX
  M28_Spy0674    SPy0888   clpL    **3.29**     **6.32**                           ATP-binding subunit clpL
  M28_Spy0943    SPy1260    \-     **2.66**                                  General stress protein, Gls24 family
  M28_Spy0945    SPy1262    \-     **2.59**                                  General stress protein, Gls24 family
  M28_Spy1286    SPy1557   msrA                 **3.73**      **2.41**    Peptide methionine sulfoxide reductase msrA
  M28_Spy0755    SPy1055   msrB    **5.36**     **4.95**      **8.23**    Peptide methionine sulfoxide reductase msrB
  M28_Spy1503    SPy1780    \-                                **2.71**          Universal stress protein family
  M28_Spy1562               \-                 **−102.42**   **−17.90**         Universal stress protein family
  M28_Spy0659    SPy0873    \-                                **2.05**               GTP pyrophosphokinase
  M28_Spy1674    SPy1981   relA    **−2.11**                 **−2.15**               GTP pyrophosphokinase
  M28_Spy1747    SPy2070   groEL                              **2.34**              60 kDa chaperonin GROEL
  M28_Spy1748    SPy2072   groES                              **2.36**              10 kDa chaperonin GROES
  M28_Spy1751    SPy2077    csp                 **2.24**      **8.50**                Cold shock protein

Values represent fold change in expression in AF at ML, LL, and S growth phases compared to expression in THY medium.

Regulatory events during growth in AF {#s3e}
-------------------------------------

We observed a large number of significant changes in transcription of regulatory genes ([Table S1](#pone.0009785.s001){ref-type="supplementary-material"}). Because the exact functions of many of these are unknown, it is impossible to predict the significance of these changes. However, we did detect changes in expression of known GAS regulators ([Table 4](#pone-0009785-t004){ref-type="table"}) such as RofA/RALP that are involved in the regulation of virulence factor expression, namely adhesins [@pone.0009785-Kreikemeyer1]. Down regulation of *rofA* in response to AF might be partially responsible for the observed decreases in the transcription of the genes encoding fibronectin binding proteins. The decreased gene expression of the regulator *ahrC.2* may be responsible for the observed changes in expression of genes involved in arginine metabolism (see below). Two other differentially expressed regulators were recently shown to be involved in GAS pathogenesis. The first, MtsR, is a regulator of ion transport and is involved in the development of necrotizing fasciitis [@pone.0009785-Beres1], [@pone.0009785-Olsen1] The second, CcpA, links GAS virulence and carbohydrate metabolism [@pone.0009785-Shelburne2]. In addition to individual regulators, we detected differential expression of seven (of 13) two component systems (TCSs) encoded by GAS. In the absence of regulation by alternative sigma factors in GAS, it is believed that concerted activity of regulons and TCSs is responsible for reaction of GAS to the environment. FasBCA and ihk/irr were shown to be involved in regulation of GAS pathogenesis. FasBCA controls expression of streptokinase, streptolysin S, and fibronectin binding proteins [@pone.0009785-Kreikemeyer2], [@pone.0009785-Steiner1]. The Ihk/Irr system is involved in GAS survival upon contact with human PMNs [@pone.0009785-Voyich1]. Circuits regulated by two other two component systems, M28_Spy0761/2 (SPy1061/2 in SF370 strain) and M28_Spy0807/8 (SPy1106/7 in SF370 strain), were studied by microarray analysis [@pone.0009785-Sitkiewicz1] and were shown to be involved in regulation of genes involved in carbohydrate and malate utilization, respectively. M28_Spy0919/20, M28_Spy1346/7 and M28_Spy1373/4 (SPy1236/7, SPy1587/8, SPy1621/2 in SF370 strain, respectively) have not been characterized thus far.

10.1371/journal.pone.0009785.t004

###### Differential expression of selected regulatory systems in response to AF.

![](pone.0009785.t004){#pone-0009785-t004-4}

  6180            SF370    Locus        ML           LL           S                      Descriptions
  ------------- --------- -------- ------------ ------------ ------------ ------------------------------------------
  M28_Spy0104    SPy0124    rofA    **−2.09**    **−3.56**    **−2.69**         Transcriptional regulator RofA
  M28_Spy0122    SPy0146    sloR    **−11.53**   **−13.76**                     Transcriptional regulator pfoR
  M28_Spy0198    SPy0242    fasB                              **−3.31**    Sensory transduction protein kinase FasB
  M28_Spy0199    SPy0244    fasC    **−2.08**    **−2.09**    **−4.77**    Sensory transduction protein kinase FasC
  M28_Spy0200    SPy0245    fasA                              **−3.61**            Response regulator FasA
  M28_Spy0356    SPy0450    mtsR                               **3.96**            Iron-dependent repressor
  M28_Spy0412    SPy0514    ccpA                              **−3.65**          Catabolite control protein A
  M28_Spy0465    SPy0584    ptsK                               **2.66**                HPR(SER) kinase
  M28_Spy0761    SPy1061     \-                               **−4.83**        Two-component sensor kinase yesM
  M28_Spy0762    SPy1062     \-                               **−3.19**     Two-component response regulator yesN
  M28_Spy0807    SPy1106    dpiA     **2.09**                              Transcriptional regulatory protein dpiA
  M28_Spy0808    SPy1107    dpiB     **2.16**                                         Sensor kinase dpiB
  M28_Spy0919    SPy1236    ciaH                              **−3.35**              Sensor protein ciaH
  M28_Spy0920    SPy1237    ciaR                              **−2.58**    Transcriptional regulatory protein ciaR
  M28_Spy1215    SPy1549   ahrC.2                             **−16.22**           Arginine repressor, argR
  M28_Spy1346    SPy1587     \-                               **−4.45**     Two-component response regulator yesN
  M28_Spy1347    SPy1588     \-                               **−3.03**        Two-component sensor kinase yesM
  M28_Spy1373    SPy1621    yvqC                               **2.05**     Two-component response regulator yvqC
  M28_Spy1374    SPy1622    yvqE                  **2.28**     **3.93**       Two-component sensor protein yvqE
  M28_Spy1708    SPy2026    ihk                               **−1.96**     Two component system histidine kinase
  M28_Spy1709    SPy2027    irr                               **−1.58**        Two-component response regulator

Values represent fold change in expression in AF at ML, LL, and S growth phases compared to expression in THY medium.

Metabolic adaptation to AF environment {#s3f}
--------------------------------------

A recently performed transcriptional analysis of GBS grown in AF revealed dramatic changes in expression of genes that control metabolism of carbohydrates, amino acids, and nucleotides [@pone.0009785-Sitkiewicz2], which presumably reflects an adaptive response to limited nutrient availability. We observed similar trends in the metabolic response of GAS to AF, with the majority of differences occurring in expression of genes involved in carbohydrate utilization ([Table S2](#pone.0009785.s002){ref-type="supplementary-material"}). In contrast to GBS that up regulates genes involved in carbohydrate utilization, GAS down regulates genes belonging to this category. Clear examples are the M28_Spy1036-1048 (*mal* genes), M28_Spy1349-1354, M28_Spy1438-1445 (*lac.1* genes), and M28_Spy1622-1629 (*lac.2* genes) loci ([Table 5](#pone-0009785-t005){ref-type="table"}). The Mal locus has been shown to be involved in GAS persistence in the oropharynx [@pone.0009785-Shelburne3], and *lac* loci are not only involved in fermentation and energy production via the tagatose pathway, but also link metabolism and the regulation of virulence [@pone.0009785-Loughman1].

10.1371/journal.pone.0009785.t005

###### Differential expression of selected genes responsible for transport and metabolism of carbohydrates.

![](pone.0009785.t005){#pone-0009785-t005-5}

  6180            SF370    Locus       ML           LL            S                           Descriptions
  ------------- --------- -------- ----------- ------------ ------------- ----------------------------------------------------
  M28_Spy0757    SPy1057     \-     **−3.86**   **−11.47**   **−18.53**           PTS system, mannose fructose family
  M28_Spy0759    SPy1059    ptsC    **−4.04**   **−7.65**    **−13.42**           PTS system, mannose fructose family
  M28_Spy0958    SPy1280    glmS    **−2.80**   **−2.01**                  Glucosamine--fructose-6-phosphate aminotransferase
  M28_Spy1036    SPy1291    glgP                              **−2.16**                Maltodextrin phosphorylase
  M28_Spy1037    SPy1292    malM                             **−14.96**                4-alpha-glucanotransferase
  M28_Spy1039    SPy1294    malE                              **−4.94**           Maltose maltodextrin-binding protein
  M28_Spy1041    SPy1296    malG    **2.19**                                   Maltose transport system permease protein
  M28_Spy1044    SPy1299    malD                             **−34.73**      Maltodextrin transport system permease protein
  M28_Spy1045    SPy1301    malC                             **−38.81**      Maltodextrin transport system permease protein
  M28_Spy1046    SPy1302    amyA                             **−82.63**             Cyclodextrin glucanotransferase
  M28_Spy1047    SPy1304    amyB    **2.06**                 **−24.86**                      Neopullulanase
  M28_Spy1048    SPy1306    malX                             **−37.14**           Maltose maltodextrin-binding protein
  M28_Spy1349    SPy1592     \-                              **−42.74**                  Sugar-binding protein
  M28_Spy1350    SPy1593     \-                              **−13.77**         Sugar transport system permease protein
  M28_Spy1351    SPy1595     \-                               **−7.07**         Sugar transport system permease protein
  M28_Spy1354    SPy1599     \-                               **−2.17**                     Beta-glucosidase
  M28_Spy1438    SPy1704   lacD.1                            **−49.45**              Tagatose-bisphosphate aldolase
  M28_Spy1440    SPy1707   lacB.1                            **−170.54**      Galactose-6-phosphate isomerase lacB subunit
  M28_Spy1441    SPy1708   lacA.1                            **−100.49**      Galactose-6-phosphate isomerase lacA subunit
  M28_Spy1442    SPy1709     \-     **2.40**                                  PTS system, galactose-specific IIC component
  M28_Spy1443    SPy1710     \-                              **−26.62**       PTS system, galactose-specific IIB component
  M28_Spy1444    SPy1711     \-                              **−57.34**       PTS system, galactose-specific IIA component
  M28_Spy1445    SPy1712   lacR.1                             **−2.47**       Lactose phosphotransferase system repressor
  M28_Spy1622    SPy1916    lacG                             **−67.36**               6-phospho-beta-galactosidase
  M28_Spy1624    SPy1918    lacF                              **−8.85**        PTS system, lactose-specific IIA component
  M28_Spy1625    SPy1919   lacD.2                            **−122.01**             Tagatose-bisphosphate aldolase
  M28_Spy1626    SPy1921   lacC.2                            **−55.33**               Tagatose-6-phosphate kinase
  M28_Spy1627    SPy1922   lacB.2                            **−21.89**       Galactose-6-phosphate isomerase lacB subunit
  M28_Spy1628    SPy1923   lacA.2                            **−69.34**       Galactose-6-phosphate isomerase lacA subunit
  M28_Spy1629    SPy1924   lacR.2                             **−3.72**       Lactose phosphotransferase system repressor
  M28_Spy1668    SPy1972    pulA                              **−5.30**                       Pullulanase
  M28_Spy1767    SPy2096    dexS                **−6.18**    **−39.01**             Trehalose-6-phosphate hydrolase
  M28_Spy1768    SPy2097     \-                 **−8.81**    **−43.06**      PTS system, trehalose-specific IIBC component

Values represent fold change in expression in AF at ML, LL, and S growth phases compared to expression in THY medium.

Another category of metabolic genes affected by growth in AF were genes involved in protein and amino acid utilization. We observed differential expression of multiple proteases, and di- and oligopeptide transport systems ([Table 6](#pone-0009785-t006){ref-type="table"}). Similarly to GBS, we observed up regulation of genes involved in uptake and utilization of branched chain amino acids (BCAA, valine, leucine, and isoleucine). GBS is auxotrophic in respect to BCAA and mobilizes all transport systems to maximize utilization from AF [@pone.0009785-Sitkiewicz2]; GAS could possibly employ the same mechanism to maximize nutrient utilization.

10.1371/journal.pone.0009785.t006

###### Differential expression of genes involved in the transport and metabolism of amino acids, peptides, and amines.

![](pone.0009785.t006){#pone-0009785-t006-6}

  6180                               SF370    Locus      ML          LL            S                       Descriptions
  -------------------------------- --------- ------- ----------- ----------- ------------- ---------------------------------------------
  Proteases                                                                                
  M28_Spy0463                       SPy0581    \-                              **−2.95**           Metallopeptidase, SprT family
  M28_Spy0470                       SPy0590    \-                 **−2.23**    **−2.82**               Peptidase family U32
  M28_Spy0471                       SPy0591    \-                              **−2.10**               Peptidase family U32
  M28_Spy0572                       SPy0775    \-                              **2.31**        Neutral zinc metallopeptidase family
  M28_Spy1136                       SPy1402    \-                              **34.77**               Peptidase family S11
  M28_Spy1397                       SPy1651   pepC    **−1.98**                                          Aminopeptidase C
  M28_Spy1565                       SPy1858   pepXP               **2.31**     **4.45**            Xaa-Pro dipeptidyl-peptidase
  M28_Spy1744                       SPy2066    \-                 **−4.28**   **−22.44**            Dipeptidase A (EC 3.4.13.-)
  M28_Spy1766                       SPy2095   pepO    **−2.78**                                 Oligoendopeptidase O (EC 3.4.24.-)
  Arginine metabolism                                                                      
  M28_Spy0575                       SPy0778    \-                              **−2.35**             Arginine-binding protein
  M28_Spy1176                       SPy1506   artP    **2.95**    **2.12**     **2.07**       Arginine transport ATP-binding protein
  M28_Spy1177                       SPy1507   artQ    **2.50**    **2.08**                  Arginine transport system permease protein
  M28_Spy1208                       SPy1541   arcC                **−8.01**   **−877.27**                Carbamate kinase
  M28_Spy1209                       SPy1542    \-                             **−199.49**               Xaa-His dipeptidase
  M28_Spy1210                       SPy1543    \-                 **−2.55**   **−191.92**          Arginine ornithine antiporter
  M28_Spy1211                       SPy1544   arcB                **−4.96**   **−212.09**         Ornithine carbamoyltransferase
  M28_Spy1213                       SPy1547   arcA                **−8.87**   **−712.24**               Arginine deiminase
  Branched chain amino acids                                                               
  M28_Spy0266                       SPy0323   braB    **5.13**    **5.26**     **2.21**      Branched-chain amino acid carrier protein
  M28_Spy0693                       SPy0911   bcaT                **2.13**     **3.48**     Branched-chain amino acid aminotransferase
  Di- and oligopeptide transport                                                           
  M28_Spy1689                       SPy2000   dppA    **−4.23**   **−2.68**                          Dipeptide-binding protein
  M28_Spy1690                       SPy2001   dppB    **−3.39**   **−2.70**                 Dipeptide transport system permease protein
  M28_Spy1691                       SPy2002   dppC    **−4.57**   **−2.82**    **−2.61**        Dipeptide transport system permease
  M28_Spy1692                       SPy2003   dppD    **−4.19**   **−2.58**    **−2.46**      Dipeptide transport ATP-binding protein
  M28_Spy1693                       SPy2004   dppE    **−4.21**   **−2.76**                   Dipeptide transport ATP-binding protein
  M28_Spy0245                       SPy0294   oppB                **2.55**                    Oligopeptide transport system permease
  M28_Spy0246                       SPy0295   oppC                **2.01**                    Oligopeptide transport system permease
  M28_Spy0247                       SPy0296   oppD                **1.75**                      Oligopeptide transport ATP-binding
  M28_Spy0248                       SPy0297   oppF                **1.89**                      Oligopeptide transport ATP-binding

Values represent fold change in expression in AF at ML, LL, and S growth phases compared to expression in THY medium.

The most dramatic changes in gene expression were observed in genes encoding enzymes of the arginine deiminase pathway, which were down regulated almost 900-fold upon contact with AF ([Table 6](#pone-0009785-t006){ref-type="table"}). The arginine deiminase pathway allows utilization of arginine as a carbon and energy source [@pone.0009785-Pierce1] and plays a role in the modification of the environmental acidity [@pone.0009785-Degnan1], [@pone.0009785-Quivey1]. Arginine deiminase from the GAS Manfredo strain is also a potent inhibitor of the proliferation of peripheral blood mononuclear cells [@pone.0009785-Degnan2]. However, arginine deiminase is not only an intracellular enzyme involved in the aforementioned processes. It can be also found on the GAS cell surface [@pone.0009785-Lei1] and antibodies against this protein have been recently reported to protect mice against GAS infection (Walker MJ, Henningham A, Cork A, Cole JN, Ramachandran V et al. (2008) Group A Anchorless Surface proteins. XVII Lancefield International Symposium on Streptococci and Streptococcal Diseases O9.2; Henningham A, Batzloff M, Cole JN, Gillen C, Hartas J et al. (2008) Protection Against lethal *Streptococcus pyogenes* challenge following vaccination with anchorless cell wall-associated proteins. XVII Lancefield International Symposium on Streptococci and Streptococcal Diseases P54). It is possible that the lack of arginine deiminase on the surface is linked to decreased recognition by the host immune response, which would be consistent with the observed down regulation of adhesins and other major surface proteins. Interestingly, fetal urine (which is a major component of AF) flow and composition is modulated by arginine levels [@pone.0009785-Modena1], therefore bacterial arginine metabolism could be linked to AF dynamics.

Arginine metabolism is linked via carbamate kinase to another pathway -- nucleotide synthesis ([Figure 4](#pone-0009785-g004){ref-type="fig"}). We observed dramatic up regulation of genes involved in purine and pyrimidine nucleotide biosynthesis pathways and down regulation of genes encoding enzymes involved in salvage pathways ([Table 7](#pone-0009785-t007){ref-type="table"}). The extent of changes in GAS correlates well with changes detected in GBS [@pone.0009785-Sitkiewicz2], and almost all of the enzymes in the nucleotide metabolic pathways undergo the same directional changes ([Figure 4](#pone-0009785-g004){ref-type="fig"}), what suggests direct influence of the AF environment.

![Changes in transcription of genes encoding predicted enzymes in the purine and pyrimidine biosynthetic pathway in GAS and GBS in response to AF.\
Both GAS and GBS exhibit similar changes in the expression of genes encoding enzymes involved in nucleotide biosynthesis. Changes in transcription of GBS genes from [@pone.0009785-Sitkiewicz2], changes in transcription of GAS genes, this work. Light green: genes down regulated 2 to 5 fold upon contact with AF; dark green: above 5 fold. Light orange: genes up regulated 2 to 5 fold upon contact with AF; dark orange: above 5 fold. R5P, ribose 5-phosphate; PRPP, phosphoribosylpyrophosphate; PRA, 5-phospho-b-D-ribosylamine; GAR, 5′-phosphoribosylglycinamide; FGAR, 5′-phosphoribosyl-N-formylglycinamide; FGAM, 5′-phosphoribosyl-N-formylglycinamidine; AIR, 5′-phosphoribosyl-5-aminoimidazole; NCAIR, 5′-phosphoribosyl-5-carboxyaminoimidazole; CAIR, 5′-phosphoribosyl-5-aminoimidazole-4-carboxylate; SAICAR, 5′-phosphoribosyl-4-(N-succino-carboxamide)-5-aminoimidazole; AICAR, 5′-phosphoribosyl-4-carboximide-5-aminoimidazole ribonucleotide; FAICAR, 5′-phosphoribosyl-4-carboximide-5-formaminoimidazole; IMP, inosine 5′-monophosphate; XMP, xanthosine monophosphate; GMP, guanosine monophosphate; GTP, guanosine triphosphate; sAMP, adenylosuccinate; AMP, adenosine monophosphate; ATP, adenosine triphosphate.](pone.0009785.g004){#pone-0009785-g004}

10.1371/journal.pone.0009785.t007

###### Differential expression of selected genes involved in nucleotide metabolism upon contact with AF.
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  6180            SF370    Locus       ML          LL           S                                  Descriptions
  ------------- --------- -------- ----------- ----------- ----------- --------------------------------------------------------------------
  M28_Spy0022    SPy0024     \-     **36.60**   **10.73**   **35.84**        Phosphoribosylaminoimidazole-succinocarboxamide synthase
  M28_Spy0024    SPy0026    purF    **24.03**   **10.89**   **13.45**                     Amidophosphoribosyltransferase
  M28_Spy0026    SPy0028    purN    **37.86**   **18.63**   **17.69**              Phosphoribosylglycinamide formyltransferase
  M28_Spy0027               purH    **17.83**   **3.68**    **3.85**        Phosphoribosylaminoimidazolecarboxamide formyltransferase
  M28_Spy0029    SPy0032    purD    **15.56**   **9.89**    **11.31**                   Phosphoribosylamine-glycine ligase
  M28_Spy0030    SPy0033    purE    **16.52**   **7.50**    **11.42**      Phosphoribosylaminoimidazole carboxylase carboxyltransferase
  M28_Spy0031    SPy0034    purK                **6.05**    **11.19**         Phosphoribosylaminoimidazole carboxylase NCAIR mutase
  M28_Spy0064    SPy0074    adk                             **−8.25**                            Adenylate kinase
  M28_Spy0134    SPy0160    purA                            **3.17**                       Adenylosuccinate synthetase
  M28_Spy0193    SPy0235     \-                             **−2.67**            Deoxyuridine 5 -triphosphate nucleotidohydrolase
  M28_Spy0316    SPy0392    upp                             **−2.43**                    Uracil phosphoribosyltransferase
  M28_Spy0334    SPy0425   nrdF.1   **−5.27**                                    Ribonucleoside-diphosphate reductase beta chain
  M28_Spy0335    SPy0426    nrdI    **−4.58**                                                      NrdI protein
  M28_Spy0336    SPy0427   nrdE.1   **−2.37**                                    Ribonucleoside-diphosphate reductase alpha chain
  M28_Spy0597    SPy0803    cmk                             **2.59**                            Cytidylate kinase
  M28_Spy0620    SPy0831    pyrP    **6.66**                                                     Uracil permease
  M28_Spy0622    SPy0833    carA    **4.79**                **−2.17**                Carbamoyl-phosphate synthase small chain
  M28_Spy0624    SPy0835    carB    **5.93**                **−2.87**                Carbamoyl-phosphate synthase large chain
  M28_Spy0658    SPy0872     \-     **68.19**   **15.18**   **11.50**                            5 -nucleotidase
  M28_Spy0668    SPy0882    thyA                            **−3.66**                          Thymidylate synthase
  M28_Spy0679    SPy0894   deoD2                            **−2.85**                    Purine nucleoside phosphorylase
  M28_Spy0683    SPy0900    pyrF    **3.45**                                           Orotidine 5 -phosphate decarboxylase
  M28_Spy0684    SPy0901    pyrE    **4.03**                                            Orotate phosphoribosyltransferase
  M28_Spy0689    SPy0907    pyrC    **2.82**    **2.39**    **2.51**                              Dihydroorotase
  M28_Spy0708    SPy0927    apt                             **−2.13**                   Adenine phosphoribosyltransferase
  M28_Spy0821    SPy1123     \-                             **2.04**                    Ribose-phosphate pyrophosphokinase
  M28_Spy0831    SPy1135    guaC    **68.20**   **23.60**   **95.96**                             GMP reductase
  M28_Spy0832    SPy1136    xpt                 **40.85**   **90.15**                   Xanthine phosphoribosyltransferase
  M28_Spy0833    SPy1137     \-     **9.77**    **45.75**   **76.46**                           Xanthine permease
  M28_Spy0897    SPy1211    rnhB                **2.92**    **8.45**             Anaerobic ribonucleoside-triphosphate reductase
  M28_Spy0899    SPy1213   fhs.1    **5.53**    **4.21**                                 Formate--tetrahydrofolate ligase
  M28_Spy0914    SPy1228     \-                             **2.11**                        Nucleoside-binding protein
  M28_Spy1109    SPy1368    udk                             **−2.04**                             Uridine kinase
  M28_Spy1118    SPy1378   nrdF.2                           **2.32**             Ribonucleoside-diphosphate reductase beta chain
  M28_Spy1159    SPy1432    pyrD                **2.15**                                   Dihydroorotate dehydrogenase
  M28_Spy1466    SPy1736     \-     **5.01**    **3.02**    **5.14**                      Guanine-hypoxanthine permease
  M28_Spy1580    SPy1869    udp                             **−2.83**                         Uridine phosphorylase
  M28_Spy1599    SPy1894    pyrG                            **−2.64**                              CTP synthase
  M28_Spy1758    SPy2085   fhs.2    **3.32**    **2.32**                                 Formate--tetrahydrofolate ligase
  M28_Spy1773    SPy2105    nrdG    **−2.00**   **−2.45**               Anaerobic ribonucleoside-triphosphate reductase activating protein
  M28_Spy1777    SPy2110    nrdD    **−2.22**   **−3.50**                        Anaerobic ribonucleoside-triphosphate reductase
  M28_Spy1890    SPy2206    guaB                            **−2.28**                 Inosine-5 -monophosphate dehydrogenase

Values represent fold change in expression in AF at ML, LL, and S growth phases compared to the expression in THY medium.

Samant et al. [@pone.0009785-Samant1] recently showed that multiple enzymes involved in nucleotide metabolism are essential for growth of *Escherichia coli* in human serum, and a bacterial growth defect can be rescued by the addition of nucleotides to the serum. To test if a lack of nucleotides or arginine/ornithine in the AF is a growth limiting factor, we tested growth of GAS in AF with the addition of selected amino acids and nucleotides (arginine, ornithine, adenine, xanthine, and uracyl at concentrations corresponding to minimal chemically defined media (CDM) concentrations for GAS [@pone.0009785-vandeRijn1]). The observed culture densities after overnight growth did not increase compared to the AF without any supplements ([Figure 5](#pone-0009785-g005){ref-type="fig"}). Therefore, the lack of arginine and nucleotides in AF is not a limiting factor for growth of GAS and up regulation of the nucleotide synthesis pathway has a distinct function from providing material for DNA synthesis. Multiple reports have suggested a connection between nucleotide metabolism and bacterial virulence [@pone.0009785-Pettersson1]. Mereghetti et al. recently reported changes in nucleotide metabolism in GBS during growth in blood and as an effect of a temperature switch [@pone.0009785-Mereghetti1], [@pone.0009785-Mereghetti2].

![Addition of arginine, ornithine, purines and pirymidines does not increase growth of GAS in AF.\
Cell densities of GAS cultures grown in pooled AF for 24 hours with addition of amino acids (arginine, ornithine) and nucleotides (xanthine, uracil, and adenine) at the concentration that supports growth of GAS in minimal CDM [@pone.0009785-vandeRijn1].](pone.0009785.g005){#pone-0009785-g005}

Summary {#s3g}
-------

Group A *Streptococcus*, a causative agent of postpartum invasive infections, is able to survive and multiply in AF. It is able to multiply and survive over 48h in the AF environment. The response of GAS is in many aspects similar to the response exhibited by GBS; however, on the contrary to GBS, GAS exhibits stronger stress response to the AF environment. GAS adapts to growth in AF by differential regulation of genes involved in arginine and nucleotide metabolism. In addition, GAS down regulates multiple cell surface proteins, presumably to escape host immune recognition.
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###### 

Differential expression of all GAS genes in response to AF. Changes in transcription of GAS genes upon contact with amniotic fluid. All changes detected in transcription of GAS in response to amniotic fluid. Values represent fold change in expression in amniotic fluid compared to expression in THY; ML, mid-logarithmic growth phase; LL, late-logarithmic growth phase; S, stationary growth phase; cut-off two fold change with P value less than 0.05. Positive values represent genes up-regulated in AF (orange), negative values represent down-regulated (green, better expressed in THY) genes. Rows marked grey denote transcripts not detected during the experiment.
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Click here for additional data file.

###### 

Comparison of transcriptional changes between GAS and GBS grown in AF. Differential expression of GAS and GBS genes in response to AF - Changes in transcription of GAS and GBS genes upon contact with amniotic fluid. Values represent fold change in expression in amniotic fluid compared to expression in THY; ML, mid-logarithmic growth phase; LL, late-logarithmic growth phase; S, stationary growth phase; cut-off two fold change with P value less than 0.05. Positive values represent genes up-regulated in AF (orange), negative values represent down-regulated (green, better expressed in THY) genes. GBS data after reference [@pone.0009785-Sitkiewicz2].
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Click here for additional data file.
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